Prognostic Value of Baseline Skeletal Muscle Index in Colorectal Cancer Patients Treated with Fruquintinib: A multi-center real world analysis
The baseline SMI was identified as an independent prognostic factor for OS and may influence the survival outcomes of patients with metastatic colorectal cancer undergoing treatment with fruquintinib. Despite the potential of fruquintinib to induce sarcopenia, no significant correlation was observed between changes in SMI following treatment and patient survival.
Authors
- Mingliang Ying (ORCID: https://orcid.org/0000-0003-2535-4043)
- Weili Xie (ORCID: https://orcid.org/0009-0009-6969-2395)
- Xuerong Xiong
- Jianfei Fu (ORCID: https://orcid.org/0000-0002-3036-1056)
- Qiusheng Guo
- Penghai Zhang (ORCID: https://orcid.org/0000-0002-9287-7592)
- Guangrong Gong
- Jinglei Zhao (ORCID: https://orcid.org/0000-0001-8375-4243)
- Fakai Li
- Hailang Chen (ORCID: https://orcid.org/0000-0002-7287-1556)
- Qinghua Wang (ORCID: https://orcid.org/0000-0002-2037-2966)
- Hangping Wei (ORCID: https://orcid.org/0000-0002-2904-7086)
- Hongjuan Zheng
- Wanfen Tang
- Cui Zhang (ORCID: https://orcid.org/0009-0005-0192-367X)
Institutions
- Wenzhou Medical University (CN)
- Fourth Affiliated Hospital of China Medical University (CN)
- Affiliated Hospital of Hangzhou Normal University (CN)
- Guang Fu Hospital (CN)
- Qujiang People's Hospital (CN)
- Wuxi People's Hospital (CN)
- Jinhua Central Hospital (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- International Journal of Colorectal Disease
- Published
- 2024-11-20
- DOI
- https://doi.org/10.1007/s00384-024-04747-z
- Citations
- 4
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.13
Funders
- Zhejiang University
- Jinhua Science and Technology Bureau
- Department of Health of Zhejiang Province